(Q42515328)

1 November 2017

title

A novel method for the determination of basal gene expression of tissue-specific promoters: an analysis of prostate-specific promoters (English)

1 reference

1 November 2017

van der Poel HG

1

1 reference

1 November 2017

McCadden J

2

1 reference

1 November 2017

Verhaegh GW

3

1 reference

1 November 2017

Kruszewski M

4

1 reference

1 November 2017

Ferrer F

5

1 reference

1 November 2017

Schalken JA

6

1 reference

1 November 2017

Carducci M

7

1 reference

1 November 2017

Rodriguez R

8

1 reference

1 November 2017

publication date

1 December 2001

1 reference

1 November 2017

1 reference

1 November 2017

volume

8

1 reference

1 November 2017

issue

12

1 reference

1 November 2017

page(s)

927-935

1 reference

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

Osteocalcin-directed gene therapy for prostate-cancer bone metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

A noncommercial dual luciferase enzyme assay system for reporter gene analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

Prostate-specific antigen expression is regulated by an upstream enhancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

The crystal structure of diphtheria toxin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

One molecule of diphtheria toxin fragment A introduced into a cell can kill the cell

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

Cloning, sequence determination, and expression in transfected cells of the coding sequence for the tox 176 attenuated diphtheria toxin A chain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

Identification of diphtheria toxin via screening as a potent cell cycle and p53-independent cytotoxin for human prostate cancer therapeutics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

A PCR-based assay for reporter gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

Analysis of promoter activity by polymerase chain reaction amplification of reporter gene mRNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

Marker proteins for gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

Prostate-specific suicide gene therapy using the prostate-specific membrane antigen promoter and enhancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

Isolation and characterization of the promoter of the human prostate cancer-specific DD3 gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700385

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700385

1 reference

Dimensions Publication ID

1 November 2017

1030213826

0 references

1 reference